« Back to Record
Citation APA

Spicka, I., Ocio, E. M., Oakervee, H. H., Greil, R., Banh, R. H., Huang, S. Y., D'Rozario, J. M., Dimopoulos, M. A., Martínez, S., Extremera, S., Kahatt, C., Alfaro, V., Carella, A. M., Meuleman, N., Hájek, R., Symeonidis, A., Min, C. K., Cannell, P., Ludwig, H., Sonneveld, P., & Mateos, M.-V. (2019). Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma. Annals of hematology, 98(9), 2139-2150. doi:10.1007/s00277-019-03739-2


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/302974

Spicka, I., Ocio, E. M., Oakervee, H. H., Greil, R., Banh, R. H., Huang, S. Y., D'Rozario, J. M., Dimopoulos, M. A., Martínez, S., Extremera, S., Kahatt, C., Alfaro, V., Carella, A. M., Meuleman, N., Hájek, R., Symeonidis, A., Min, C. K., Cannell, P., Ludwig, H., Sonneveld, P., & Mateos, M.-V. (2019). Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma. Annals of hematology, 98(9), 2139-2150. doi:10.1007/s00277-019-03739-2